The ad is also facing criticism as it focuses on the brands GLP-1 solution but fails to address the concerns that come with this type of medication, such as muscle loss and bone loss
Patients should also report persistent fatigue, headache, or malaise that significantly impacts daily functioning or does not improve within one to two weeks of medication initiation or dose adjustment
Sudden shortness of breath, especially with exertion, is the most common
GLP-1 receptor agonists (GLP-1s) have gained popularity as a treatment for diabetes and weight loss
Chronic low-grade inflammation around follicles contributes to miniaturization and eventual hair loss in many individuals
Understanding the TrimRx Approach We believe that medical weight loss should be accessible, transparent, and personalized